Md Salman Ashrafi

About Author:

SOCIAL LINK:

Salman brings over three years of experience in uncovering stories behind startups and economic trends. With a solid background in finance and research, he’s passionate about decoding business models and analyzing stocks.

Blogs by Md Salman Ashrafi

Reliance Q4 Results Are Out! Stock Up 5%

Reliance Q4 FY25 Results: Posts 10% Revenue Growth, Stock Jumps 5%

Reliance Q4 Results & Earnings FY25 - Revenue grows 10%, profit surges 6%. After result announcement, Reliance stock price rose 5%. Get financial highlights at INDmoney.

Md Salman Ashrafi

Published in Stocks

7 months ago

Vikran Engineering IPO: All You Need to Know

Vikran Engineering IPO Subscribed 5.5x on Day 2; Retail, HNIs Drive Demand as GMP Weakens

Vikran Engineering IPO Day 2 update: Subscription surges 5.5x led by retail and NIB demand, while GMP cools to ₹12. Read insights on demand, grey market trend, positives, and risks.

Md Salman Ashrafi

Published in IPO

3 months ago

Capillary Technologies IPO: Invest or Avoid?

Capillary Technologies IPO Review, GMP, Valuation - Invest or Avoid?

A detailed review of Capillary Technologies IPO - GMP trend, risks, strengths, valuation analysis, peer comparison, and analyst view, to help you make an informed decision.

Md Salman Ashrafi

Published in IPO

7 days ago

TruAlt Bioenergy IPO: Is It Worth Your Money?

TruAlt Bioenergy IPO Day 3: Weak Subscription but GMP Rises - What Investors Should Track

TruAlt Bioenergy IPO Day 2 saw 0.81x overall subscription with QIBs at 0.86x, Retail at 0.79x, and NII at 0.8x. GMP climbed to ₹95. Read expert insights on fundamentals, risks, valuations, and listing outlook.

Md Salman Ashrafi

Published in IPO

2 months ago

Paytm Share Tumbles 10% After Govt Rejects MDR Comeback

Paytm's stock fell 10% after a government announcement on MDR. Our simple guide explains why this happened and what it means for Paytm's future.

Md Salman Ashrafi

Published in Stocks

5 months ago